NeoGenomics (NEO) Tops Q4 EPS by 1c, Revenues Beat; Offers FY19 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street futures edge lower after AI selloff, telecom slide
- Brent crude hits more than five-month high on concern over Middle East escalation
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- UBS sees dip buyers stepping in to support gold at this level
| NEOGENOMICS (NASDAQ: NEO) | Delayed: 16.39 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.39 | 52 Week High | $9.54 | |||
| Open | $16.39 | 52 Week Low | $5.49 | |||
| Day High | $16.39 | P/E | 409.75 | |||
| Day Low | $16.39 | EPS | $0.04 | |||
| Volume | 20,397 | |||||
